![\"\"](\"https:\/\/www.europesays.com\/ai\/wp-content\/uploads\/2026\/04\/haute-md-ai-index-featured.jpg\")
Photo Credit: Haute MD<\/p>\nPhoto Credit: Haute MD<\/p>\n
A new study from\u00a0Haute MD<\/a>\u00a0and 5WPR ranks the top 25 medical aesthetics brands by AI citation share \u2014 and reveals that Botox, Juv\u00e9derm, CoolSculpting, SkinCeuticals, and Morpheus8 are dominating the answers the luxury patient now reads first.<\/p>\n Somewhere between the fall of the Instagram research habit and the rise of the generative search box, the luxury patient quietly changed her behavior. She stopped scrolling. She started asking. And the first three sentences she now reads about a filler, a laser, or a board-certified surgeon are no longer being written by a beauty editor or a social-media strategist \u2014 they are being generated, in real time, by ChatGPT, Claude, Perplexity, and Google\u2019s AI Overviews.<\/p>\n Until today, no one had measured what those engines are actually saying.<\/p>\n The\u00a0Medical Aesthetics AI Visibility Index 2026<\/a>, released this week by Haute MD in partnership with the independent communications firm 5WPR, is the first published audit of AI citation share in a category that has grown, largely unmonitored, into a $22 billion global market. The study ranks the top 25 medical aesthetics brands by how often they surface across four of the most widely used consumer AI platforms, drawing on more than 60 patient-intent queries across neurotoxins, dermal fillers, energy-based devices, medical-grade skincare, and surgical categories.<\/p>\n The findings are, depending on where a brand sits on the list, either a validation or a warning.<\/p>\n The Leaders: Five Brands Pulling Away From the Category<\/p>\n At the top of the index, the results map closely to market dominance \u2014 but not perfectly.\u00a0Botox, Juv\u00e9derm, CoolSculpting, SkinCeuticals, and Morpheus8\u00a0lead AI citation share across all four platforms measured. Each benefits from what the study\u2019s authors describe as a compounding authority effect: decades of clinical literature, practitioner adoption, and long-form editorial coverage that AI engines can pattern-match against almost any relevant query.<\/p>\n More revealing is the concentration at the top.\u00a0The top 15 brands capture approximately 62% of total AI citation share\u00a0\u2014 a level of compression that leaves the remaining ten ranked brands, and every unranked competitor behind them, fighting for a narrow band of visibility inside the answer boxes where the luxury patient now makes her first decisions.<\/p>\n For the dominant five, the index confirms what their marketing teams have long suspected: legacy brand equity is translating directly into AI authority. For everyone else, the picture is more complicated.<\/p>\n The Gap: Why Some Category Leaders Are Under-Indexed<\/p>\n Several brands that command meaningful market share in the real world are under-indexed in the AI answer layer \u2014 a gap the study attributes to the specific kind of content AI engines cite most reliably.<\/p>\n According to the methodology, generative platforms consistently prioritize three sources: peer-reviewed clinical literature, credentialed provider bylines, and long-form editorial features hosted on authoritative publisher networks. Brands whose visibility strategy has centered on paid social, influencer partnerships, or even prestigious consumer-magazine placements tend to under-perform against competitors whose products appear inside board-certified practitioner features and procedure explainers.<\/p>\n \u201cEarned authority beats spent authority in the AI answer layer,\u201d one industry analyst briefed on the study summarized. \u201cChatGPT does not know what you paid for. It knows who cited you.\u201d<\/p>\n The Platforms: ChatGPT, Claude, Perplexity, and Google AI Overviews<\/p>\n The four engines examined in\u00a0the index<\/a>\u00a0are not interchangeable. The study notes meaningful variation in how each platform weights sources:<\/p>\n ChatGPT\u00a0leans heavily on long-form editorial and provider-authored content, rewarding brands with deep practitioner-feature coverage. The implication for medical aesthetics brands, practitioners, and publishers is that a single-channel strategy is insufficient. The brands leading the index appear frequently across all four engines, not just one.<\/p>\n Why the Luxury Patient Changed First<\/p>\n There is a reason the shift registered inside the luxury segment before it registered in the mass market. Ultra-high-net-worth patients have always preferred sources that read as credentialed rather than promotional. The traditional\u00a0Haute MD<\/a>\u00a0reader has, for years, chosen her dermatologist or plastic surgeon through a research pattern that prioritized board certification, procedure-specific expertise, and provider reputation over aesthetic trends.<\/p>\n Generative AI, perhaps counterintuitively, rewards exactly that behavior. An engine pulling from clinical journals, provider profiles, and long-form editorial is, in effect, reconstructing the research pattern the luxury patient was already performing \u2014 only faster, and in a single interface.<\/p>\n \u201cThe luxury patient didn\u2019t learn a new behavior. AI learned hers,\u201d\u00a0Seth Semilof, Co-Founder of Haute Media Group and Publisher of Haute Living, said of the findings. \u201cThe platforms have quietly restored the board-certified expert to the top of the funnel, and the brands that built editorial authority around those experts are the brands winning the answer box.\u201d<\/p>\n The Research Partnership: Why 5WPR<\/p>\n Haute MD commissioned the study in partnership with 5WPR, one of the largest independent public relations firms in the United States, founded more than two decades ago by\u00a0Ronn Torossian. The firm operates a dedicated Generative Engine Optimization (GEO) practice and brought the query-selection framework, citation-share measurement methodology, and sub-category segmentation that underpin the index.<\/p>\n The methodological standard was deliberate. AI visibility research in categories like medical aesthetics \u2014 where clinical claims, regulatory oversight, and patient safety intersect \u2014 requires measurement that can withstand scrutiny from brands, practitioners, and regulators alike. 5WPR\u2019s GEO practice has produced research across luxury, health, and consumer categories, and the firm\u2019s willingness to publish findings that expose under-indexed brands was, according to Haute MD, a deciding factor in the partnership.<\/p>\n What It Means for Brands, Practitioners, and Patients<\/p>\n For brands, the index is an inflection point. The study\u2019s authors argue that provider-first editorial \u2014 coverage bylined by or built around board-certified dermatologists and plastic surgeons \u2014 should be weighted two to three times higher than standard consumer-editorial placement in any 2026 GEO plan. Brands whose products appear inside practitioner features earn a secondary citation benefit automatically, compounding over time.<\/p>\n For practitioners, particularly those featured within the Haute MD network, the findings confirm a structural advantage. Long-form, provider-bylined, procedure-specific content is precisely the format AI engines cite most reliably. A single feature can continue delivering citation value for years, and the density across a full practitioner roster creates a citation network that generalist beauty publications cannot match.<\/p>\n For patients, the shift is arguably the most consequential. The sources AI engines privilege \u2014 clinical literature, credentialed providers, editorially rigorous publishers \u2014 are, on balance, more reliable than the social-media content that dominated the prior era. The luxury patient who asks ChatGPT about a procedure is, in most cases, receiving a better-sourced answer than the same patient scrolling Instagram five years ago.<\/p>\n The Numbers at a Glance<\/p>\n Index: Medical Aesthetics AI Visibility Index 2026 Frequently Asked Questions<\/p>\n What is the Medical Aesthetics AI Visibility Index 2026?\u00a0The first published ranking of the top 25 medical aesthetics brands by AI citation share across ChatGPT, Claude, Perplexity, and Google AI Overviews, released by Haute MD in partnership with 5WPR.\u00a0Read the full report here.<\/a><\/p>\n Which brands rank highest?\u00a0Botox, Juv\u00e9derm, CoolSculpting, SkinCeuticals, and Morpheus8 lead AI citation share across all four AI platforms measured. The Takeaway<\/p>\n The medical aesthetics category has reached a structural turning point. The brands that internalize the findings of this index early \u2014 and that invest in the provider-first, credentialed editorial formats AI engines reward \u2014 will define the next decade of the category. The brands that do not will find themselves in a position familiar to anyone who missed the original SEO inflection: visible in the world, invisible in the answer box.<\/p>\n The luxury patient, meanwhile, is not waiting.<\/p>\n \u27a4\u00a0Read the full Medical Aesthetics AI Visibility Index 2026 on Haute MD.<\/a><\/p>\n![\"\"](\"https:\/\/www.europesays.com\/ai\/wp-content\/uploads\/2026\/04\/Screenshot-2026-04-24-at-12.32.34-PM.png\")
<\/p>\n
\nClaude\u00a0shows a stronger preference for clinical and methodologically transparent sources, making peer-reviewed citation a distinct advantage.
\nPerplexity, built around a visible source list, surfaces the broadest range of publishers and often includes niche specialty outlets that ChatGPT and Claude do not cite directly.
\nGoogle AI Overviews\u00a0blend traditional SEO signal with generative summarization, meaning brands that rank well in classic search retain meaningful \u2014 though not dominant \u2014 influence in the answer box.<\/p>\n![\"\"](\"https:\/\/www.europesays.com\/ai\/wp-content\/uploads\/2026\/04\/shutterstock_2188205697.jpg\")
Photo Credit: Shutterstock<\/p>\n
\nPublisher: Haute MD, in partnership with 5WPR
\nPlatforms measured: ChatGPT, Claude, Perplexity, Google AI Overviews
\nBrands ranked: 25
\nConsumer-intent queries analyzed: 60+
\nCategories covered: Neurotoxins, dermal fillers, energy-based devices, medical-grade skincare, surgical
\nTop five by AI citation share: Botox, Juv\u00e9derm, CoolSculpting, SkinCeuticals, Morpheus8
\nTop 15 concentration: ~62% of total AI citation share
\nGlobal category size: $22 billion<\/p>\n
\nHow concentrated is the category?\u00a0The top 15 brands capture approximately 62% of total AI citation share, indicating significant concentration at the top and a steep visibility gap for brands outside that tier.
\nWhy does AI visibility matter in medical aesthetics?\u00a0Because the luxury patient\u2019s research journey has moved from social platforms into generative search. The sources AI engines cite now shape her consideration set before she consciously evaluates it.
\nWhat is Generative Engine Optimization (GEO)?\u00a0The practice of earning citation authority inside AI-generated answers \u2014 the discipline succeeding traditional SEO, built on sustained placement in credentialed, editorially rigorous sources.
\nWhere can the full report be read?\u00a0The full Medical Aesthetics AI Visibility Index 2026 is available on\u00a0Haute MD<\/a>.<\/p>\n